Sept. 4, 2025 — University Hospitals health system in Cleveland recently became the first healthcare institution in the United States to install the Naeotom Alpha.Pro from Siemens Healthineers, the world’s second dual-source scanner with photon-counting computed tomography (PCCT) technology.

Sept. 4, 2025 — 4DMedical, a global medical technology company, has announced U.S. Food and Drug Administration (FDA) 510(k) clearance for CT:VQ, the world's the company's non-contrast, ventilation–perfusion (V/Q) imaging solution. In parallel, the U.S. Centers for Medicare & Medicaid Services (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes; this payment is in addition to existing reimbursement for the underlying chest CT.

Using AI to Detect Tiny Brain Metastases

Brain metastases are 10 times more common than primary brain tumors, occurring in 10 to 20% of adult patients with cancer.1 The current limit of detection clinically is 2 to 5 mm in diameter, though metastases are more typically detected between 5 mm and 1 cm.2 Yet in their earliest stages, metastases can be 3 mm or smaller, making them challenging to identify on an MRI.

Sept. 2, 2025 — As American hospitals continue to grapple with an increasing shortage of specialized medical imaging technologists, a new partnership is turning a little-known hardware device into a critical lifesaving tool. Currently, the U.S. is facing a radiographer staffing shortfall of 15.6%, with experts continuing to sound the alarm.

Aug. 29, 2025 — GE HealthCare has launched Vivid Pioneer, its most advanced, ultra-premium and adaptive cardiovascular ultrasound system yet, completely redesigned to support clinicians with imaging in 2D, 4D and color flow, streamlined workflow, and enhanced diagnostic confidence. The ultrasound system recently received CE Mark and U.S. FDA 510(k) clearance.

The Vivid Pioneer is on display during the European Society of Cardiology 2025, Aug. 29–Sept., 1 in Madrid, Spain. 

Aug.  26, 2025 — In a quest for ever-more-effective treatments for pancreatic cancer, HonorHealth Research Institute is combining the power of targeted drugs and ultra-sound technology to shrink the tumors of patients whose cancer has not spread to other parts of the body but is too advanced to allow safe surgical removal.

American Society for Radiation Oncology (ASTRO) 67th Annual Meeting

HIMSS Global Health Conference & Exhibition

Aug. 26, 2025— Esaote North America, Inc., a provider of dedicated MRI, Ultrasound, and Healthcare IT solutions, has announced a strategic partnership with Epica International, a global provider in advanced CT and imaging technologies. This collaboration unites two complementary portfolios to expand market presence and accelerate the adoption of high-performance MRI and CT solutions across the human and veterinary healthcare sectors.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now